FIELD: medicine; pharmacology.
SUBSTANCE: invention relates to medicine, in particular to pharmacology, and concerns new application of known linear substituted glyproline – ethyl ether of N-phenylacetylglycyl-L-proline (GZK-111) as analgesic agent. It is established that N-phenylacetylglycyl-L-proline has both antidepressant and analgesic effect.
EFFECT: new application of linear substituted glyproline.
1 cl, 1 dwg, 2 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL GLYPROLINS WITH NOOTROPIC, ANTI-HYPOXIC, NEUROPROTECTIVE AND ANSSIYLITIS ACTIVITY | 2016 |
|
RU2646604C2 |
| LOW-MOLECULAR MIMETIC BDNF AS AN AGENT FOR TREATING OPIOID DEPENDENCE | 2019 |
|
RU2707301C1 |
| AGENT POSSESSING ANTIDIABETIC ACTIVITY | 2017 |
|
RU2693479C2 |
| PHARMACEUTICAL COMPOSITION BASED ON BIS-(N-MONOSUCCINYL-L-SERYL-L-LYSINE) HEXAMETHYLENEDIAMIDE (GSB-106) | 2018 |
|
RU2697254C1 |
| LOW MOLECULAR WEIGHT MIMETIC OF BRAIN NEUROTROPHIC FACTOR WITH ANALGESIC, ANXIOLYTIC AND ANTIADDICTIVE EFFECTS | 2020 |
|
RU2759023C2 |
| METHOD FOR PREVENTION AND TREATMENT OF CARBOHYDRATE AND LIPID METABOLISM DISORDER IN METABOLIC SYNDROME AND ENCEPHALOPATHY, USE OF TETRAPEPTIDE AND PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF SUCH DISORDERS | 2012 |
|
RU2480234C1 |
| METHOD OF TREATING DIABETES IN MAMMALS AND INTRANASAL PHARMACEUTICAL COMPOSITION FOR TREATING DIABETES IN MAMMALS | 2009 |
|
RU2403909C1 |
| ANALGESIC AGENT OF PEPTIDE STRUCTURE OF UNDERCAPEPTIDE CONTAINING D-OCTAARGININE VECTOR | 2013 |
|
RU2541127C1 |
| LIGANDS OF TRANSLOCATOR PROTEIN TSPO, HAVING ANTIDEPRESSANT AND NOOTROPIC ACTIVITY | 2015 |
|
RU2699568C2 |
| 1,4-BENZODIAZEPIN-2-ONE DERIVATIVES AND USE THEREOF | 2017 |
|
RU2701557C2 |
